Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure

<p>Abstract</p> <p>The 2012 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV-1 reservoirs and cure research. Combi...

Full description

Bibliographic Details
Main Authors:	Lafeuillade Alain, Soriano Vicente, Suzan-Monti Marie, Stevenson Mario, Izopet Jacques, Stellbrink Hans-Jürgen
Format:	Article
Language:	English
Published:	BMC 2012-08-01
Series:	AIDS Research and Therapy
Subjects:	HIV pandemic HIV cure HIV reservoirs Antiretroviral therapy HCV coinfection Access to care New anti-HCV drugs
Online Access:	http://www.aidsrestherapy.com/content/9/1/23

Similar Items

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID)
by: Jean-Pierre Routy, et al.
Published: (2016-07-01)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
by: Solange Zacalusni Freitas, et al.
Published: (2014-12-01)

Sustained virological response according to the type of early virological response in HCV and HCV/HIV
by: Paulo R. Lerias de Almeida, et al.
Published: (2010-04-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01)

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients
by: Ricardo A. Carmo, et al.

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

HIV/HCV coinfection model: a fractional-order perspective for the effect of the HIV viral load
by: Ana RM Carvalho, et al.
Published: (2018-01-01)

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Efficacy Of Pegylated Interferon And Ribavirin Treatment In Coinfected HIV HCV Patients
by: Dumitru Irina Magdalena, et al.
Published: (2017-02-01)

Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus
by: K V Shmagel, et al.
Published: (2016-11-01)

Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study
by: G. Ionita, et al.
Published: (2017-07-01)

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
by: E. V. Saidakova, et al.
Published: (2014-07-01)

Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the antiretroviral therapy received Avaliação clínico-laboratorial de pacientes co-infectados com o vírus da hepatite C e HIV-1 em relação ao tipo de terapia antirretroviral recebida
by: Roberto M. Carrasco Navarro, et al.
Published: (2005-02-01)

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
by: Yue Chen, et al.
Published: (2016-11-01)

Modeling the Impact of Needle Exchange Programs Accounting for both HIV and HCV Infections and HIV/CV Co-Infections
by: Huang, GEORGE
Published: (2014)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
by: Óscar Brochado, et al.
Published: (2021-03-01)

Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1
by: Marcia Moreira, et al.

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection
by: Mario Peribañez-Gonzalez, et al.
Published: (2013-03-01)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
by: Yu Wang, et al.
Published: (2021-09-01)

Highlights from the HIV Cure and Reservoir Symposium, 11–12 September 2017, Ghent, Belgium
by: Sam Kint, et al.
Published: (2018-01-01)

Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review
by: Fatima Mitiko Tengan, et al.
Published: (2016-11-01)

High hepatitis C virus infection among female sex workers in Viet Nam: strong correlation with HIV and infection drug use
by: Linh-Vi N Le, et al.
Published: (2019-11-01)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
by: Beatriz Álvarez, et al.
Published: (2020-06-01)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
by: Óscar Brochado-Kith, et al.
Published: (2021-08-01)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
by: Adele S. Benzaken, et al.
Published: (2019-08-01)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
by: Victor Virlogeux, et al.
Published: (2017-12-01)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
by: Martinez Valrie, et al.
Published: (2012-07-01)

Prevalence and genetic diversity of HCV among HIV-1 infected individuals living in Ahvaz, Iran
by: Ali Teimoori, et al.
Published: (2019-05-01)

Effect of HCV on lipids profile of HIV patients
by: Mehrnaz Rasoolinejad, et al.
Published: (2012-02-01)

Detection of HIV and HCV RNA in semen from Brazilian coinfected men using multiplex PCR before and after semen washing Detecção do RNA do HIV e HCV em sêmen de homens brasileiros, usando PCR multiplex antes e depois do "semen washing"
by: Cynthia Liliane Motta do Canto, et al.
Published: (2006-08-01)

Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus
by: Ruthie Birger, et al.
Published: (2015-09-01)

Expressão do HLA-G no tecido hepático de pacientes coinfectados com HIV/HCV
by: Vilar, Fernando Crivelenti
Published: (2014)

Expressão do HLA-G no tecido hepático de pacientes coinfectados com HIV/HCV
by: Fernando Crivelenti Vilar
Published: (2014)

Evaluation of the therapeutic response of hepatitis C in coinfected patients (HIV/HCV): a study of cases from a hospital for chronic liver diseases in the Eastern Brazilian Amazon
by: Ivanete do Socorro Abraçado Amaral, et al.
Published: (2013-01-01)

Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA
by: Christina K. Psomas, et al.
Published: (2018-04-01)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
by: Tiziana Latronico, et al.
Published: (2016-03-01)

Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil
by: Cintia Costi, et al.

Hepatitis C Virus Influences HIV-1 Viral Splicing in Coinfected Patients
by: Paula Martínez-Román, et al.
Published: (2020-07-01)

Clinical and immunological characteristic of natural course at the early stages of HIV infection
by: E. R. Manapova, et al.
Published: (2020-05-01)